+ All Categories
Home > Documents > (2/28) Schlemmer Lecture: Pharmacology of Drugs used to treat … · 2019. 1. 6. · (2/28)...

(2/28) Schlemmer Lecture: Pharmacology of Drugs used to treat … · 2019. 1. 6. · (2/28)...

Date post: 06-Oct-2020
Category:
Upload: others
View: 2 times
Download: 0 times
Share this document with a friend
2
(2/28) Schlemmer Lecture: Pharmacology of Drugs used to treat Angina Coronary Artery Disease (CAD): Also known as ASCVD, Coronary Heart Disease (CHD), and Ischemic HD - Epidemiology: 1 in 3 adults has a variation of cardiovascular disease, >13mil have CAD and ~9mil have Angina o #1 cause of death, higher in AA. The greater the number of vessels occluded à worse outcome - Pathophysiology: Fatty streaks can be considered normal, essentially all adults have them. However, when plaques build up, they can become obstructive atherosclerotic plaques. Associated inflammatory processes further promote occlusion, and although often clinically silent, severe occlusions may require bypass surgery - Complications: Angina pectoris, MI, HF, Ventricular arrhythmias, Death Angina: Term for chest pain or discomfort attributed to Coronary artery disease (CAD) - Sx: Pressure, squeezing, pain in the center of the heart ~ sternum/left side of chest - Cx: Pain results from acidic metabolites stimulating myocardial pain nerve-endings. The accumulation of metabolites secondary to myocardial ischemia will effectively decreasing oxygen supply to the extent that the demands of myocardial oxygen balance are not met. - Electric: The ST segment connects the QRS complex to the T wave, and represents the ventricular repolarization phase. Normally, it is flat. - Stable Angina: Inducible by moderate effort. Coronary artery functions on reduced capacity, quickly relieved by rest or nitroglycerin - Unstable Angina: Also referred to as acute coronary syndrome, this type of angina may be provoked even when resting. Atherosclerotic plaques rupture, clotting to form a plug, blocking flow to the heart muscle. Unstable angina should be treated as a medical emergency - Prinzmetal’s Angina: An unstable variation of angina whereby spasms cause reductions in blood flow. This may occur in or in absence of atherosclerotic disease. It is also referred to as Vasospastic angina Treatment of Angina - The aim of treatment dictates the style of treatment. To impart long-term prevention, we must stop the progression of atherosclerosis, made possible inhibiting platelet activation, fibrinolytic activities, and inflammatory abnormalities. Sometimes, to relieve or avert the onset of pain, we require significant lifestyle changes and potentially even surgery. Surgery includes, angioplasty, stents, and coronary bypass. o Short-term goals: Reduce or prevent angina symptoms that impair quality of life o Long-term goals: Prevent MI, arrhythmias, HF, and extend the patient’s life. - Nitrate Therapy: Nitrates are the classic prototype drugs used for short-term relief of Angina o à Reduce myocardial O 2 demand o Sublingual and Translingual formulations are used to terminate acute angina and as acute prophylaxis o Ointments and Patches are used for sustained protection against angina attacks throughout the day - b-Blocker Therapy: The mainstay therapy for Chronic stable angina o à Reduce myocardial O 2 demand Nitrates: Nitroglycerin - MoA: Upon entering the vascular smooth muscle, Nitroglycerin dissociates off Nitric Oxide (NO) which activates guanylyl cyclase. Guanylyl cyclase increases cGMP formation which dephosphorylates myosin light chains à Vascular smooth muscle relaxes o Predominantly act at the venous capacitance vessels and large coronary arteries to induce relaxation - Standard Dose: Dilation of systemic veins, causing blood to pool within veins (Ývenous capacitance), and decreasing venous return to the heart. This reduces the workload of the heart, reducing myocardial O 2 demand. o Coronary/Epicardial Arteries: Will be relaxed. This reduces spasm of variant angina and increases coronary perfusion thereby aiding oxygen delivery. - Higher Doses:, Arteriolar resistance begins to decrease, further reducing the workload of the heart due to lack of an afterload resistance. Extensive venous pooling continues, and overall blood pressure will decrease. - AE: High doses may trigger the baroreceptor reflex, producing reflex tachycardia and dizzy spells. This may frighten the patient, so it is worth counseling them on – it is safe and to be expected. Additionally: o Headaches (cerebral vasodilation), Cutaneous flushing (arterial dilation of face), postural hypotension - ContraX: Nitrates should not be used in combination with other nitrates. A PDE-5 inhibitor, sildenafil (Viagra) increases cGMP thereby potentiating nitrate activity. Due to the risk of life-threatening hypotension, drugs for sexual-activity should not be used. Try some meditation therapy or something instead o Viagra: Avoid nitrate therapy for 24 hours following most recent Viagra/Levitra dosing o Cialis: Avoid nitrate therapy for 36 hours following most recent Cialis dosing (longer duration of action) - Metabolism/PK: Nitrates have very low oral bioavailability (<10-20%) due to both chemistry and a significant first-pass effect by nitrate reductase in the liver. As a result, sublingual dosing is preferred as it avoids first-pass
Transcript
Page 1: (2/28) Schlemmer Lecture: Pharmacology of Drugs used to treat … · 2019. 1. 6. · (2/28) Schlemmer Lecture: Pharmacology of Drugs used to treat Angina Coronary Artery Disease (CAD):

(2/28) Schlemmer Lecture: Pharmacology of Drugs used to treat Angina Coronary Artery Disease (CAD): Also known as ASCVD, Coronary Heart Disease (CHD), and Ischemic HD

- Epidemiology: 1 in 3 adults has a variation of cardiovascular disease, >13mil have CAD and ~9mil have Angina o #1 cause of death, higher in AA. The greater the number of vessels occluded à worse outcome

- Pathophysiology: Fatty streaks can be considered normal, essentially all adults have them. However, when plaques build up, they can become obstructive atherosclerotic plaques. Associated inflammatory processes further promote occlusion, and although often clinically silent, severe occlusions may require bypass surgery

- Complications: Angina pectoris, MI, HF, Ventricular arrhythmias, Death Angina: Term for chest pain or discomfort attributed to Coronary artery disease (CAD)

- Sx: Pressure, squeezing, pain in the center of the heart ~ sternum/left side of chest - Cx: Pain results from acidic metabolites stimulating myocardial pain nerve-endings. The accumulation of

metabolites secondary to myocardial ischemia will effectively decreasing oxygen supply to the extent that the demands of myocardial oxygen balance are not met.

- Electric: The ST segment connects the QRS complex to the T wave, and represents the ventricular repolarization phase. Normally, it is flat.

- Stable Angina: Inducible by moderate effort. Coronary artery functions on reduced capacity, quickly relieved by rest or nitroglycerin

- Unstable Angina: Also referred to as acute coronary syndrome, this type of angina may be provoked even when resting. Atherosclerotic plaques rupture, clotting to form a plug, blocking flow to the heart muscle. Unstable angina should be treated as a medical emergency

- Prinzmetal’s Angina: An unstable variation of angina whereby spasms cause reductions in blood flow. This may occur in or in absence of atherosclerotic disease. It is also referred to as Vasospastic angina

Treatment of Angina - The aim of treatment dictates the style of treatment. To impart long-term prevention, we must stop the progression

of atherosclerosis, made possible inhibiting platelet activation, fibrinolytic activities, and inflammatory abnormalities. Sometimes, to relieve or avert the onset of pain, we require significant lifestyle changes and potentially even surgery. Surgery includes, angioplasty, stents, and coronary bypass.

o Short-term goals: Reduce or prevent angina symptoms that impair quality of life o Long-term goals: Prevent MI, arrhythmias, HF, and extend the patient’s life.

- Nitrate Therapy: Nitrates are the classic prototype drugs used for short-term relief of Angina o à Reduce myocardial O2 demand o Sublingual and Translingual formulations are used to terminate acute angina and as acute prophylaxis o Ointments and Patches are used for sustained protection against angina attacks throughout the day

- b-Blocker Therapy: The mainstay therapy for Chronic stable angina o à Reduce myocardial O2 demand

Nitrates: Nitroglycerin - MoA: Upon entering the vascular smooth muscle, Nitroglycerin dissociates off

Nitric Oxide (NO) which activates guanylyl cyclase. Guanylyl cyclase increases cGMP formation which dephosphorylates myosin light chains à Vascular smooth muscle relaxes

o Predominantly act at the venous capacitance vessels and large coronary arteries to induce relaxation - Standard Dose: Dilation of systemic veins, causing blood to pool within veins (Ývenous capacitance), and

decreasing venous return to the heart. This reduces the workload of the heart, reducing myocardial O2 demand. o Coronary/Epicardial Arteries: Will be relaxed. This reduces spasm of variant angina and increases

coronary perfusion thereby aiding oxygen delivery. - Higher Doses:, Arteriolar resistance begins to decrease, further reducing the workload of the heart due to lack of

an afterload resistance. Extensive venous pooling continues, and overall blood pressure will decrease. - AE: High doses may trigger the baroreceptor reflex, producing reflex tachycardia and dizzy spells. This may

frighten the patient, so it is worth counseling them on – it is safe and to be expected. Additionally: o Headaches (cerebral vasodilation), Cutaneous flushing (arterial dilation of face), postural hypotension

- ContraX: Nitrates should not be used in combination with other nitrates. A PDE-5 inhibitor, sildenafil (Viagra) increases cGMP thereby potentiating nitrate activity. Due to the risk of life-threatening hypotension, drugs for sexual-activity should not be used. Try some meditation therapy or something instead

o Viagra: Avoid nitrate therapy for 24 hours following most recent Viagra/Levitra dosing o Cialis: Avoid nitrate therapy for 36 hours following most recent Cialis dosing (longer duration of action)

- Metabolism/PK: Nitrates have very low oral bioavailability (<10-20%) due to both chemistry and a significant first-pass effect by nitrate reductase in the liver. As a result, sublingual dosing is preferred as it avoids first-pass

Page 2: (2/28) Schlemmer Lecture: Pharmacology of Drugs used to treat … · 2019. 1. 6. · (2/28) Schlemmer Lecture: Pharmacology of Drugs used to treat Angina Coronary Artery Disease (CAD):

o Onset: 2-5 mins, effects wear off within 30 minutes. - Dosing: To treat angina, allow 1 tablet to dissolve under tongue. If there is no pain relief after 5 minutes or if pain

worsens, contact emergency medical services. Take maximum 3 tablets DIV q5min while waiting for ambulance Nitrates: Isosorbide dinitrate: This compound is an improved PO formulation that has 4-6 hours of action. Still, the sublingual route for this drug is preferred.

- Mononitrate? The activate metabolite of the dinitrate formulation. Isosorbide mononitrate is an available prescription medication with excellent bioavailability and longer T1/2

o IR (Ismo, Monoket): Take 1 tab 2 times daily spaced 7 hours apart [provides nitrate free interval] o SR (Imdur): Take 1 tab Qdaily [Has a built-in interval]

- Tolerance: Sustained use will lead to desensitization producing tachyphylaxis – meaning there will be a loss of hemodynamic and anti-anginal effects following repeated dosing. This effect can develop in as little as 24 hours. Tolerance can be avoided by including nitrate-free intervals – of which is considered in the formulation of patches

- AE + ContraX: Refer to those listed for Nitroglycerin Beta-Blockers (BB): Each BB is equally effective in its treatment of angina. YES, can be combined with nitrates. The added benefit of combined therapy is that BB can help prevent the reflex tachycardia associated with Nitrates. WOW!

- MoA: Competitively inhibit catecholamine binding at b adrenoceptors (specifically b1). As a result, left ventricular wall stress is reduced thereby reducing blood pressure, in addition to heart rate and contractility. It is also hypothesized there is an increase in coronary blood flow due to Ýdiastole resonance

- Non-Selective: Propranolol - Cardioselective: Atenolol and Metoprolol are the most common. However, this cardioselectivity can be lost at the

higher doses when used to treat angina. - AE: BB are generally well-tolerated. However, high doses or intolerant individuals can produce a therapeutic

response that is too intense, such as bradycardia or excessive fatigue/CNS fatigue o Bronchoconstriction due to b2 adrenergic blockade (Non-selective agents or high dose cardioselective) o Worsening of PAD or Raynaud’s Fatigue CNS effect (nightmares, insomnia) o Erectile Dysfunction related to hypotension

Calcium Channel Blockers (CCB) - MoA (Myocytes): Block initial Ca2+ influx associated with formation of Ca2+-Troponin complexes in the heart

muscle. Ca2+-Troponin allows actin and myosin to contract. CCB à Decreased contractility - MoA (Vasculature): Block initial Ca2+ influx associated with formation of Ca2+-calmodulin complexes in the

vascular smooth muscle. Normally, this complex permits actin + myosin to contract. CCB à Vasodilation - Dihydropyridines: Exhibit greater selectivity for the vascular smooth muscle than myocardium

o Efficacy: Vasodilate the coronary arteries and reduce resistance, improving coronary blood flow o AE: Strong reflex tachycardia, so significant that it can lead to ischemia. Peripheral vasodilation may lead

to peripheral edema, flushing headaches - Verapamil: A negative inotrope (force) and negative chronotrope (~HR), Verapamil will lower the systemic

blood pressure, decreasing myocardial oxygen o Caution: Excessive negative inotropic/chronotropic effects may occur in combination with a BB

Ranolazine (Ranexa) - Place in Therapy: Used in late treatment for patients with chronic stable angina who have failed other therapies

o May be used concurrently with BB, Nitrates, and Amlodipine (but not other CCB) - MoA: Inhibits late entry of Na+ into cardiac myocytes; thereby reducing intracellular Na+. As a result, Na+/Ca2+

antiporter will attempt to compensate, thereby significantly reducing intracellular Ca2+, which is proposed to help the myocardium use energy more efficiently

- AE: May cause prolongation of QT interval, as well as increase BP o ContraX: Patients taking potent or moderately potent inhibitors of CYP3A4 (diltiazem, verapamil) are at

increased risk of QT prolongation.


Recommended